HomeAbout UsContact Us
Advanced Search
All CoursesCourses by TopicCourses by SpecialtyCourses by Specialty CreditRegister Now!!
Register Now!!
Member Login
Your Account
Your Test History
Your Certificates
All Courses
Courses by Topic
Courses by Specialty
Courses by Specialty Credit
Featured Programs
Other Resources
Home : Advanced Search : Course view

This course is no longer active as of 2008-01-05

Course: Improving Outcomes in Oncologic Supportive Care: Important Topics Related to Erythropoietic Intervention in the Management of Chemotherapy-induced Anemia 

Specialty: Hematology/Oncology Format: Multimedia 
Course #: 6313  Price: FREE  
Release date: 2007-01-05  Valid through: 2008-01-05  
Course viewing requirements  (opens in a new window)
Instructions for Course Participation  (opens in a new window)
Legal disclaimer  (opens in a new window)

Target Audience:
This continuing medical education activity has been developed for physicians who treat anemia in cancer patients
This educational activity is jointly sponsored by Thomson Professional Postgraduate Services® and Thomson Interphase.
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Thomson Professional Postgraduate Services®, Secaucus, NJ, and Thomson Interphase. Thomson Professional Postgraduate Services® is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation:
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.
John Glaspy, MD
Professor of Medicine
Division of Hematology-Oncology
Department of Medicine
UCLA School of Medicine
Los Angeles, California

Michael Perlmutter, MS, PharmD
Scientific Director, Thomson Interphase
Secaucus, New Jersey

Educational Reviewer
The peer review for this activity was completed by CME Peer Review, LLC.

  • Improving Outcomes in Oncologic Supportive Care: Important Topics Related to Erythropoietic Intervention in the Management of Chemotherapy-induced Anemia
  • Explain dosing schedules that have been used to synchronize erythropoietic therapy with chemotherapy administration
  • Discuss methods by which the efficacy of currently available erythropoietic therapy may be improved
  • Discuss data concerning the safety of erythropoiesis stimulating proteins when used to treat cancer-related anemia
Financial Disclosure:
John Glaspy, MD, acknowledges that he has received grant/research support from Amgen, Ortho Biotech, and Roche Pharmaceuticals.

Michael Perlmutter, MD, PharmD, has disclosed that he has no relevant affiliations or financial interests in any of the coporate organziations involved with products to which this program refers.

CME Peer Review, LLC, has indicated no relevant financial realtionships to disclose.

Off-label Disclosure
Throughout the activity, information marked with * denotes off-label use that is not yet approved by the FDA.

If you have any comments or queries about this activity please contact Thomson Postgraduate Professional Services at www.ppscme.org/contactus.htm or by email at PPS.CME.Feedback@pps.thomson.com.

© Copyright 2007 Thomson Professional Postgraduate Services® and Thomson Interphase. All rights reserved.
This course is no longer available to take.


This educational activity is supported by an educational grant from Amgen.